Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii

There are currently no defined optimal therapies available for multidrug-resistant (MDR) Acinetobacter baumannii infections. We evaluated the efficacy of rifampin, imipenem, sulbactam, colistin, and their combinations against MDR A. baumannii in experimental pneumonia and meningitis models. The bact...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Pachón-Ibáñez, María E., Docobo-Pérez, Fernando, López-Rojas, Rafael, Domínguez-Herrera, Juan, Jiménez-Mejias, Manuel E., García-Curiel, Andrés, Pichardo, Cristina, Jiménez, Luis, Pachón, Jerónimo
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology (ASM) 2010
נושאים:
Experimental Therapeutics
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2825983/
https://ncbi.nlm.nih.gov/pubmed/20047914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00367-09
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים